Chemicalinfo Chemlink Pharm-Chem Net

Study of Lonafarnib Versus Placebo in Subjects With Either Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML) (Study P02978AM3)(TERMINATED)This study has been terminated. Sponsored by: Scherin...

Cediranib (AZD2171, RECENTIN™) in Addition to Chemotherapy in Patients With Untreated Metastatic Colorectal Cancer (HORIZON II)This study is currently recruiting participants. Verified by AstraZeneca, June 2008 Sponsored...

in-PharmaTechnologist.com's periodic round-up of developments in the field of pharmaceutical facilities includes news of two environmental fines, MHRA plant approval and a strike at Teva.....

UK-based Sinclair Pharmaceuticals has entered into a manufacturing and distribution agreement with Wockhardt, an Indian pharmaceutical and biotech company.....

Biotechnology firm ProGen Pharmaceuticals has spun-out its manufacturing operations as the new wholly-owned subsidiary PharmaSynth......

Heart failure linked to Sutent treatment July 2, 2008 NEW YORK (Reuters Health) - Kidney and stomach cancer patients given the chemotherapy drug Sutent (also called sunitinib), especially thos...

Published at www.nejm.org July 2, 2008 (10.1056/NEJMe0804521) Noninvasive Monitoring of TumorsJoan H. Schiller, M.D. Noninvasive Monitoring of Tumors -->Joan H. Schiller, M.D.-->The treatment of non–small-cell lung cancer has made limited ...

Wednesday, July 2, 2008New treatment option for patients with liver cancer Treatment with sunitinib (Sutent) slows tumour growth and reduces the risk of metastasis in patients with hepatocellular carcinoma, an aggressive cancer of the liver.Hepatocel...

Promising New Tool to Monitor Lung Cancer Treatment ProgressArticle date: 2008/07/02Researchers at Massachusetts General Hospital (MGH) are testing a non-surgical technique that may help doctors monitor how well non-small cell lung cancer patien...

国家工商行政管理总局、工业和信息化部、公安部、国家食品药品监督管理局关于治理化工类企业非法生产经营蛋白同化制剂、肽类激素的公告